P

Inventor

MAN HON-WAH

US129 patents
⚠️ This page may combine multiple inventors who share the name “MAN HON-WAH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELGENE CORP

39 patents
US7244759B2Jul 17, 2007

Isoindoline compounds and methods of making and using the same

CELGENE CORP138 citations99
US7091353B2Aug 15, 2006

Isoindole-imide compounds, compositions, and uses thereof

CELGENE CORP147 citations99
US6962940B2Nov 8, 2005

(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof

CELGENE CORP107 citations99
US6020358AFeb 1, 2000

Substituted phenethylsulfones and method of reducing TNFα levels

CELGENE CORP296 citations99
US6011050AJan 4, 2000

Substituted phenethylsulfones and method of reducing TNFα levels

CELGENE CORP172 citations99
US5955476ASep 21, 1999

Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels

CELGENE CORP267 citations99
US5874448AFeb 23, 1999

Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels

CELGENE CORP285 citations99
US7893101B2Feb 22, 2011

Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

CELGENE CORP44 citations98
US7635700B2Dec 22, 2009

5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same

CELGENE CORP78 citations98
US6667316B1Dec 23, 2003

Pharmaceutically active isoindoline derivatives

CELGENE CORP88 citations98
US6326388B1Dec 4, 2001

Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level

CELGENE CORP115 citations98
US7427638B2Sep 23, 2008

(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof

CELGENE CORP53 citations97
US7659303B2Feb 9, 2010

Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4- acetylaminoisoindoline-1,3-dione

CELGENE CORP21 citations96
US7659302B2Feb 9, 2010

Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione

CELGENE CORP35 citations96
US7507759B2Mar 24, 2009

Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione

CELGENE CORP21 citations96
US7358272B2Apr 15, 2008

Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione

CELGENE CORP21 citations96
US6911464B2Jun 28, 2005

N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses

CELGENE CORP41 citations96
US6214857B1Apr 10, 2001

Substituted alkanohydroxamic acids and method of reducing TNFα levels

CELGENE CORP76 citations96
US9724330B2Aug 8, 2017

Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

CELGENE CORP7 citations93
US9499514B2Nov 22, 2016

Antiproliferative compounds and methods of use thereof

CELGENE CORP28 citations93
US9283207B2Mar 15, 2016

Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

CELGENE CORP7 citations93
US9018243B2Apr 28, 2015

Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

CELGENE CORP13 citations93
US8802717B2Aug 12, 2014

Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione

CELGENE CORP13 citations93
US7820697B2Oct 26, 2010

Compositions and method for reducing TNFα levels

CELGENE CORP27 citations93
US7405237B2Jul 29, 2008

Isoindoline compounds and methods of their use

CELGENE CORP12 citations93
US6656964B2Dec 2, 2003

Method of inhibiting phosphodiesterases with substituted alkanohydroxamic acids

CELGENE CORP18 citations93
US10357489B2Jul 23, 2019

Antiproliferative compounds and methods of use thereof

CELGENE CORP20 citations92
US9828361B2Nov 28, 2017

Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same

CELGENE CORP12 citations92
US8012997B2Sep 6, 2011

Isoindole-imide compounds, compositions, and uses thereof

CELGENE CORP30 citations92
US7576104B2Aug 18, 2009

Isoindole-imide compounds, compositions, and uses thereof

CELGENE CORP24 citations92
US7511072B2Mar 31, 2009

7-amido-isoindolyl compounds and methods of its use

CELGENE CORP16 citations92
US7256210B2Aug 14, 2007

7-amido-isoindolyl compounds and methods of their use

CELGENE CORP24 citations92
US7173058B2Feb 6, 2007

Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses

CELGENE CORP20 citations92
US7034052B2Apr 25, 2006

7-Amido-isoindolyl compounds and their pharmaceutical uses

CELGENE CORP32 citations92
US6762195B2Jul 13, 2004

Pharmaceutically active isoindoline derivatives

CELGENE CORP29 citations92
US6699899B1Mar 2, 2004

Substituted acylhydroxamic acids and method of reducing TNFα levels

CELGENE CORP45 citations91
US10092542B2Oct 9, 2018

Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

CELGENE CORP4 citations84
US9920027B2Mar 20, 2018

4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same

CELGENE CORP4 citations84
US9822094B2Nov 21, 2017

Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same

CELGENE CORP9 citations84

MULLER GEORGE W

3 patents

MULLER GEORGE

2 patents

SIGNAL PHARM LLC

2 patents

(unassigned)

1 patent

MAN HON-WAH

1 patent

RUCHELMAN ALEXANDER L

1 patent

UNIV WASHINGTON

1 patent

Showing the top 50 of 129 patents by PatentIndex Score.